Concourse Financial Group Securities’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6266 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6951 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6943 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6957 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6956 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6885 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6726 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6568 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6336 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6342 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6163 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 6113 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5996 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5967 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5797 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5605 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5427 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5278 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5080 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4948 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4914 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 4851 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 4654 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4794 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 4726 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4614 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4375 |
|